Literature DB >> 1941010

Epidemiology of headache in a general population--a prevalence study.

B K Rasmussen1, R Jensen, M Schroll, J Olesen.   

Abstract

We present the first prevalence study of specific headache entities using the operational diagnostic criteria of the International Headache Society. One thousand 25-64 year old men and women, who lived in the western part of Copenhagen County were randomly drawn from the Danish National Central Person Registry. All subjects were invited to a general health examination focusing on headache and including: a self-administered questionnaire concerning sociodemographic variables, a structured headache interview and a general physical and neurological examination. The participation rate was 76%. Information about 79% of the non-participants showed a slightly differing headache prevalence which was not quantitatively important. The following results in participants are therefore representative of the total sample. The lifetime prevalences of headache (including anybody with any form of headache), migraine, and tension-type headache were 93, 8 and 69% in men; and 99, 25 and 88% in women. The point prevalence of headache was 11% in men and 22% in women. Prevalence of migraine in the previous year was 6% in men and 15% in women and the corresponding prevalences of tension-type headache were 63 and 86%. Differences according to sex were significant with a male: female ratio of 1:3 in migraine, and 4:5 in tension-type headache. The prevalence of tension-type headache decreased with increasing age, whereas migraine showed no correlation to age within the studied age interval. Headache disorders are extremely prevalent and represent a major health problem, which merits increased attention.

Entities:  

Mesh:

Year:  1991        PMID: 1941010     DOI: 10.1016/0895-4356(91)90147-2

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  238 in total

Review 1.  A review of the treatment of primary headaches. Part II: Tension-type headache.

Authors:  D D'Amico; L Grazzi; M Leone; F Moschiano; G Bussone
Journal:  Ital J Neurol Sci       Date:  1998-02

Review 2.  Headache.

Authors:  T J Steiner; Manuela Fontebasso
Journal:  BMJ       Date:  2002-10-19

3.  Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations.

Authors:  Katharina Eikermann-Haerter; Jeong Hyun Lee; Izumi Yuzawa; Christina H Liu; Zhipeng Zhou; Hwa Kyoung Shin; Yi Zheng; Tao Qin; Tobias Kurth; Christian Waeber; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

Review 4.  Central and peripheral sensitization in tension-type headache.

Authors:  Lars Bendtsen
Journal:  Curr Pain Headache Rep       Date:  2003-12

5.  [Altered cerebral excitability and spreading depression. Causes for the comorbidity of epilepsy and migraine?].

Authors:  T Leniger; H C Diener; A Hufnagel
Journal:  Nervenarzt       Date:  2003-06-18       Impact factor: 1.214

6.  Multiple-dose pharmacokinetics of intranasally administered IS-159 in healthy subjects.

Authors:  Paul L M Van Giersbergen; Jasper Dingemanse
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Jan-Mar       Impact factor: 2.441

Review 7.  Tension-type headache and women: do sex hormones influence tension-type headache?

Authors:  Jessica Ailani
Journal:  Curr Pain Headache Rep       Date:  2010-12

Review 8.  Tricyclic and Tetracyclic Antidepressants for the Prevention of Frequent Episodic or Chronic Tension-Type Headache in Adults: A Systematic Review and Meta-Analysis.

Authors:  Jeffrey L Jackson; Josephine M Mancuso; Sarah Nickoloff; Rebecca Bernstein; Cynthia Kay
Journal:  J Gen Intern Med       Date:  2017-07-18       Impact factor: 5.128

9.  Adverse reactions attributed to sumatriptan. A postmarketing study in general practice.

Authors:  J P Ottervanger; T B van Witsen; H A Valkenburg; D E Grobbee; B H Stricker
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

10.  Initial Abortive Treatments for Migraine Headache.

Authors:  Sylvia Lucas
Journal:  Curr Treat Options Neurol       Date:  2002-09       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.